IPO registrations (S-1, F-1) · Registrants
Medpace Holdings, Inc.
- SEC CIK
- 1668397 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2016-06-24, last 2016-08-01; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2016-08-11; declared effective 2016-08-10
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- 5375 MEDPACE WAY, Cincinnati, OH 45227
- EIN
- 32-0434904
- Ticker
- MEDP (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Medpace Holdings, Inc. on the corporate pages
Offering terms
- Proposed price range
- $20.00–$23.00 per share (S-1/A filed 2016-08-01)
- Final price
- $23.00 per share, within the range (424B4 filed 2016-08-11, an initial public offering)
- Shares sold
- 7,000,000
- Gross proceeds
- $161,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol MEDP
- Lead underwriters
- Jefferies; Credit Suisse
- Syndicate
- UBS; Wells Fargo; Baird; William Blair
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: Medpace Holdings, Inc. EXACT (CIK (EXACT))
- Person page: Mr Stephen P Ewald Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2016-06-24 | S-1 | S-1 (registration) | Medpace Holdings, Inc. | 0001193125-16-631490 ↗ |
| 2016-07-26 | S-1/A | S-1/A (amendment) | Medpace Holdings, Inc. | 0001193125-16-657278 ↗ |
| 2016-08-01 | S-1/A | S-1/A (amendment) | Medpace Holdings, Inc. | 0001193125-16-665568 ↗ |
| 2016-08-10 | EFFECT | EFFECT (declared effective) | Medpace Holdings, Inc. | 9999999995-16-005402 ↗ |
| 2016-08-11 | 424B4 | 424B4 (final prospectus) | Medpace Holdings, Inc. | 0001193125-16-679354 ↗ |
| 2017-10-23 | EFFECT | EFFECT (declared effective) | Medpace Holdings, Inc. | 9999999995-17-002752 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2016-08-01 | S-1/A | registration statement | $20.00–$23.00 | 7,000,000 | - | Nasdaq MEDP | 6 | primary document; range, shares headline, cover names 6 | document ↗ | |
| 2016-08-11 | 424B4 | final prospectus | $23.00 | 7,000,000 | $161,000,000 | Nasdaq MEDP | 6 | primary document; price sentence, shares headline, proceeds table, cover names 6 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BUCKNELL PENELOPE J | Officer | VP, Human Resources | 4 | 2016–2017 | |
| BURWIG SUSAN E | Officer | Exec. VP, Operations; Sr. Vice President, Operations | 40 | 2016–2026 | |
| Carley Brian T | Director | 35 | 2016–2026 | ||
| Cinven Capital Management (V) General Partner Ltd | TenPercentOwner | 7 | 2016–2018 | ||
| Cinven Capital Management (V) Limited Partnership Inc | TenPercentOwner | 7 | 2016–2018 | ||
| Cinven Manco S.A.R.L. | TenPercentOwner | 2 | 2016–2017 | ||
| EWALD STEPHEN P | Officer | General Counsel & Corp. Secy. | 31 | 2016–2026 | person page Fuzzy |
| Fifth Cinven Fund Co-Investment Partnership | TenPercentOwner | 2 | 2016–2017 | ||
| Fifth Cinven Fund FCP-SIF | TenPercentOwner | 2 | 2016–2017 | ||
| Fifth Cinven Fund (No. 1) Limited Partnership | TenPercentOwner | 2 | 2016–2017 | ||
| Fifth Cinven Fund (No. 2) Limited Partnership | TenPercentOwner | 2 | 2016–2017 | ||
| Fifth Cinven Fund (No. 3) Limited Partnership | TenPercentOwner | 2 | 2016–2017 | ||
| Fifth Cinven Fund (No. 4) Limited Partnership | TenPercentOwner | 2 | 2016–2017 | ||
| Fifth Cinven Fund (No. 5) Limited Partnership | TenPercentOwner | 2 | 2016–2017 | ||
| Fifth Cinven Fund (No. 6) Limited Partnership | TenPercentOwner | 2 | 2016–2017 | ||
| GEIGER JESSE J | Officer | CFO & COO, Lab Operations; President | 31 | 2016–2026 | |
| Kraft Robert O. | Director | 35 | 2016–2026 | ||
| LESLIE ALEXANDER F S | Director | 1 | 2016 | ||
| NORTON MATTHEW RICHARD | Director | 1 | 2016 | ||
| RAJAGOPALAN SUPRAJ R | Director | 1 | 2016 | ||
| Troendle August J. | Director,Officer,TenPercentOwner | CEO; President & CEO | 164 | 2016–2026 | |
| Medpace Investors, LLC | TenPercentOwner | 116 | 2016–2024 | ||
| Brown Bruce | Director | 6 | 2016–2019 | ||
| Medpace GP Ltd | TenPercentOwner | 7 | 2017–2018 | ||
| Medpace Limited Partnership | TenPercentOwner | 7 | 2017–2018 | ||
| DAVENPORT FRED B JR | Director | 14 | 2018–2026 | ||
| McCarthy Cornelius P. III | Director | 34 | 2018–2026 | ||
| Keating Ashley M. | Director | 14 | 2019–2024 | ||
| King Tom C | Director | 7 | 2019–2022 | ||
| Brady Kevin M. | Officer | CFO & Treasurer | 12 | 2021–2026 | |
| Gwadry-Sridhar Femida H. | Director | 6 | 2023–2026 | ||
| Zander Dani S. | Director | 4 | 2024–2026 | ||
| Hansman Brad W. | Officer | Exec. VP, Operations | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | Medpace Holdings, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Mr Stephen P Ewald | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, OH first:
- KENDLE INTERNATIONAL INC OH
- NETMED INC OH
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
- DGI RESOLUTION INC K6
- PRA INTERNATIONAL INC VA
- QUEST DIAGNOSTICS INVESTMENTS INC NJ
- SIGNAL PHARMACEUTICALS INC CA
- CURAGEN CORP MA
- DELTAGEN INC CA
In other datasets, the same topic (Medical research) in OH:
- Form D issuer: Advanced Nanotherapies Inc. (Form D private offerings)
- Nonprofit: 46BROOKLYN RESEARCH (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research